/ CompletedNot Applicable Safety and Effectiveness Study Comparing Dabigatran, Rivaroxaban & Apixaban in Non-valvular Atrial Fibrillation Patients Enrolled in the US Department of Defense Military Health System
The purpose of this study is to assess the safety and effectiveness of newly initiated dabigatran among patients diagnosed with non valvular atrial fibrillation (NVAF) in comparison to newly initiated rivaroxaban users and newly initiated apixaban users
100 Clinical Results associated with Health ResearchTx, LLC (HRTX)
0 Patents (Medical) associated with Health ResearchTx, LLC (HRTX)
100 Deals associated with Health ResearchTx, LLC (HRTX)
100 Translational Medicine associated with Health ResearchTx, LLC (HRTX)